{
  "trial_id": "NCT02873351",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "diagnosis of intermediate or advanced dry AMD",
      "label": "met",
      "evidence": "documented in medical record"
    },
    {
      "criterion": "taking AREDS vitamin supplements",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "previous prescription for L-DOPA or dopamine agonist medications",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "concurrent use of monoamine oxidase (MAO) inhibitors",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "eye condition that can impair vision",
      "label": "met",
      "evidence": "documented in medical record"
    },
    {
      "criterion": "neurologic conditions that can impair vision",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Parkinson's Disease",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "dark adaptation rod intercept < 6.5 minutes",
      "label": "met",
      "evidence": "lab study results"
    },
    {
      "criterion": "significant orthostatic hypotension",
      "label": "not_met",
      "evidence": "physical exam and lab study results"
    },
    {
      "criterion": "significant ECG abnormalities",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has a documented diagnosis of Wegener's granulomatosis, which is an exclusion criterion. However, the patient is also taking corticosteroid and cyclophosphamides, which may be relevant to the study.",
  "_meta": {
    "topic_id": "54",
    "trial_id": "NCT02873351",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}